RFK Jr cancels $500 million in mRNA research, HHS to prioritize ‘safer’ vaccine alternatives
A total of 22 mRNA vaccine development contracts totaling roughly $500 million have been canceled, the Department of Health and...
Read moreA total of 22 mRNA vaccine development contracts totaling roughly $500 million have been canceled, the Department of Health and...
Read moreSenate Republicans are mulling whether to go nuclear after negotiations with Senate Democrats to ram through President Donald Trump’s nominees...
Read moreSen. Tom Cotton, R-Ark., is calling on the Internal Revenue Service (IRS) to revoke the nonprofit status of a Muslim...
Read moreWASHINGTON — The Agriculture Department allowed six additional states Monday to bar participants in the Supplemental Nutrition Assistance Program from...
Read moreThe Interior Department looks to curb massive, unreliable and environmentally-damaging energy projects, citing wind and solar, per a new order...
Read moreDisclaimer: Thefinancialhorizons.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Disclaimer: Thefinancialhorizons.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.